Identification of a Novel Coronavirus in Patients with Severe Acute Respiratory Syndrome
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index; 1 of the 9 sources its claims cite were checked for support.
Abstract
BACKGROUND: The severe acute respiratory syndrome (SARS) has recently been identified as a new clinical entity. SARS is thought to be caused by an unknown infectious agent. METHODS: Clinical specimens from patients with SARS were searched for unknown viruses with the use of cell cultures and molecular techniques. RESULTS: A novel coronavirus was identified in patients with SARS. The virus was isolated in cell culture, and a sequence 300 nucleotides in length was obtained by a polymerase-chain-reaction (PCR)-based random-amplification procedure. Genetic characterization indicated that the virus is only distantly related to known coronaviruses (identical in 50 to 60 percent of the nucleotide sequence). On the basis of the obtained sequence, conventional and real-time PCR assays for specific and sensitive detection of the novel virus were established. Virus was detected in a variety of clinical specimens from patients with SARS but not in controls. High concentrations of viral RNA of up to 100 million molecules per milliliter were found in sputum. Viral RNA was also detected at extremely low concentrations in plasma during the acute phase and in feces during the late convalescent phase. Infected patients showed seroconversion on the Vero cells in which the virus was isolated. CONCLUSIONS: The novel coronavirus might have a role in causing SARS.
Overview
CoChat Summary
## TL;DR
The paper identifies a previously unknown coronavirus in patients with severe acute respiratory syndrome (SARS) and provides PCR and serologic evidence linking it to the illness. It also reports that viral RNA was found at very high levels in sputum, with lower-level detection in plasma and later in stool, supporting a respiratory infection with possible additional shedding routes.
## Key findings
- A novel coronavirus was isolated from sputum of the index patient after 6 days of incubation in Vero-cell culture, and a 300-nucleotide sequence was obtained by random RT-PCR.
- Genetic analysis found the virus was only distantly related to known coronaviruses, with the BNI-1 sequence differing by 39% to 46% from known sequences and by 50% to 60% identical nucleotide sequence to known coronaviruses.
- In the Hanoi outbreak panel, the virus was detected in 100% of patients with probable SARS, 23% of those with suspected SARS, and 0% of healthy contacts.
- Quantitative PCR found viral RNA concentrations of up to 100 million molecules per milliliter in sputum; the index patient also had RNA in plasma at 190 (day 9) and stool on day 25, and Contact 1 had 6.3 × 10^4 in sputum and 4.1 × 10^5 in BAL.
## Methods
- Clinical specimens from SARS patients were screened for known and unknown pathogens using cell culture, electron microscopy, PCR, antigen ELISA, serology, and sequence/phylogenetic analysis.
- The study examined specimens from 3 patients in Frankfurt (index patient, Contact 1, Contact 2) and a panel of 49 specimens from 18 suspected/probable SARS patients and 21 healthy contacts in Hanoi, plus 54 stool controls from Germany.
- A random RT-PCR approach and subsequent nested and real-time RT-PCR assays were developed to identify and quantify the novel virus, with specificity tested against several other coronaviruses.
## Limitations
- The paper itself states that larger studies with appropriate control groups are needed to verify or reject the hypothesis that this virus causes SARS.
- The authors note that the antibody response might not be definitively directed against the novel coronavirus, because the antigen used in serology came from primary cultures; they say this should be tested with plaque-purified virus or recombinant proteins.
- Evidence of causation is not established here; the paper shows association and detection in patients, but the conclusion is only that the virus “might have a role” in causing SARS.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
1 Valid · 0 Not valid · 7 Not checked · 67 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The presence of viral RNA in stool of the patients late during convalescence is reminiscent of characteristics of other coronaviruses. 13”
What the sources say
- Partly supportedcites [13] matched to “Evaluation of concurrent shedding of bovine coronavirus via the respiratory tract and enteric route in feedlot cattle” (2001) sourceExperimental — accuracy not yet measured
Our copy of Cho et al (2001) supports only the general point that a bovine coronavirus is present/shed in feces: fecal samples from 56 feedlot steers were positive for BCV by antigen-capture ELISA and virus isolation (Results, p. 1; Materials and Methods, Sample Collections), and the Discussion (p. 6) notes 22% of fecal samples from cattle without diarrhea were antigen-positive, suggesting they 'had diarrhea during shipping or at the auction barn and were still shedding BCV'. The specific elements the citing sentence attributes are absent: detection was of antigen/infectious virus, not viral RNA (no RT-PCR assay appears anywhere in our copy; RT-PCR of feces belongs to a work it cites, Tsunemitsu and Saif, ref 35), samples were taken only on days 0, 4, 14 and 21 after arrival rather than late during convalescence, in cattle rather than human patients, and the paper makes no comparative statement about shared characteristics of other coronaviruses. (LLM, conf=0.62)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Infected patients showed seroconversion on the Vero cells in which the virus was isolated.”
- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“About 20 distinct DNA fragments were obtained and sequenced.”
plainSingle case- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Three of the fragments did not match any nucleotide sequence in the data base.”
plainSingle case- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“since there was serologic evidence of an acute infection with this virus in our index patient and also in Contact 1”
plainn = 2- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
50 more claims
Create a free account to see all 75 claims and to verify the 7 references still open.
- It may state two separate claims as one. 11
- Probably not a substantial claim. 11
Citations
Cites
PHYLIP-Phylogeny inference package (Version 3.2)
Felsenstein, J. (1989) · Cladistics · Cited by 17,682
Identification of Severe Acute Respiratory Syndrome in Canada
Poutanen, S. M., Low, D. E., Henry, B., Finkelstein, S., Rose, D., Green, K., Tellier, R., Draker, R., Adachi, D., Ayers, M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030634 · Cited by 1,132
A Cluster of Cases of Severe Acute Respiratory Syndrome in Hong Kong
Tsang, K. W., Ho, P. L., Ooi, G. C., Yee, W. K., Wang, T., Chan-Yeung, M., Lam, W. K., Seto, W. H., Yam, L. Y., Cheung, T. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030666 · Cited by 1,017
Viruses and bacteria in the etiology of the common cold
Mäkelä, M. J., Puhakka, T., Ruuskanen, O., Leinonen, M., Saikku, P., Kimpimäki, M., Blomqvist, S., Hyypiä, T., & Arstila, P. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.2.539-542.1998 · Cited by 768
Drosten, C., Göttig, S., Schilling, S., Asper, M., Panning, M., Schmitz, H., & Günther, S. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.7.2323-2330.2002 · Cited by 631
Self-citationImported Lassa Fever in Germany: Molecular Characterization of a New Lassa Virus Strain
Günther, S., Emmerich, P., Laue, T., Kühle, O., Asper, M., Jung, A., Grewing, T., ter Meulen, J., & Schmitz, H. (2000) · Emerging Infectious Diseases · doi:10.3201/eid0605.000504 · Cited by 200
Self-citationStephensen, C. B., Casebolt, D. B., & Gangopadhyay, N. N. (1999) · Virus Research · doi:10.1016/s0168-1702(99)00017-9 · Cited by 135
Cho, K.-O., Hoet, A. E., Loerch, S. C., Wittum, T. E., & Saif, L. J. (2001) · American Journal of Veterinary Research · doi:10.2460/ajvr.2001.62.1436 · Cited by 88
TTV a common virus, but pathogenic?
Cossart, Y. E. (1998) · The Lancet · doi:10.1016/s0140-6736(05)77802-8 · Cited by 44
HGV: hepatitis G virus or harmless G virus?
Kew, M. C., & Kassianides, C. (1996) · The Lancet · doi:10.1016/s0140-6736(96)98020-4 · Cited by 39
Research works printed but not linked: 2
- 2003, Wkly Epidemiol Rec, 78, 81
- 2003, Wkly Epidemiol Rec, 78, 73
Cited by
Items 401–500 of 1,020
The role of extracellular vesicles in COVID-19 virus infection
Hassanpour, M., Rezaie, J., Nouri, M., & Panahi, Y. (2020) · Infection, Genetics and Evolution · doi:10.1016/j.meegid.2020.104422 · Cited by 226
Han, H., Xie, L., Liu, R., Yang, J., Liu, F., Wu, K., Chen, L., Hou, W., Feng, Y., & Zhu, C. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25809 · Cited by 235
van Elden, L. J. R., van Loon, A. M., van Alphen, F., Hendriksen, K. A. W., Hoepelman, A. I. M., van Kraaij, M. G. J., Oosterheert, J., Schipper, P., Schuurman, R., & Nijhuis, M. (2004) · The Journal of Infectious Diseases · doi:10.1086/381207 · Cited by 225
Membrane Binding Proteins of Coronaviruses
J Alsaadi, E. A., & Jones, I. M. (2019) · Future Virology · doi:10.2217/fvl-2018-0144 · Cited by 230
Lee, W.-M., Grindle, K., Pappas, T., Marshall, D. J., Moser, M. J., Beaty, E. L., Shult, P. A., Prudent, J. R., & Gern, J. E. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.02501-06 · Cited by 224
Severe Acute Respiratory Syndrome
Christian, M. D., Poutanen, S. M., Loutfy, M. R., Muller, M. P., & Low, D. E. (2004) · Clinical Infectious Diseases · doi:10.1086/420743 · Cited by 218
Viral Innate Immune Evasion and the Pathogenesis of Emerging RNA Virus Infections
Nelemans, T., & Kikkert, M. (2019) · Viruses · doi:10.3390/v11100961 · Cited by 225
Brug, J., Aro, A. R., & Richardus, J. H. (2009) · International Journal of Behavioral Medicine · doi:10.1007/s12529-008-9000-x · Cited by 214
A new threat from an old enemy: Re‑emergence of coronavirus (Review)
Docea, A., Tsatsakis, A., Albulescu, D., Cristea, O., Zlatian, O., Vinceti, M., Moschos, S., Tsoukalas, D., Goumenou, M., Drakoulis, N., et al. (2020) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2020.4555 · Cited by 218
Wang, C., Deng, R., Gou, L., Fu, Z., Zhang, X., Shao, F., Wang, G., Fu, W., Xiao, J., Ding, X., et al. (2020) · Annals of Translational Medicine · doi:10.21037/atm-20-3391 · Cited by 219
Schönrich, G., Raftery, M. J., & Samstag, Y. (2020) · Advances in Biological Regulation · doi:10.1016/j.jbior.2020.100741 · Cited by 220
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): a Systemic Infection
Synowiec, A., Szczepański, A., Barreto-Duran, E., Lie, L. K., & Pyrc, K. (2021) · Clinical Microbiology Reviews · doi:10.1128/cmr.00133-20 · Cited by 212
Identification of 14 Known Drugs as Inhibitors of the Main Protease of SARS-CoV-2
Ghahremanpour, M. M., Tirado-Rives, J., Deshmukh, M., Ippolito, J. A., Zhang, C.-H., Cabeza de Vaca, I., Liosi, M.-E., Anderson, K. S., & Jorgensen, W. L. (2020) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.0c00521 · Cited by 218
Virus Detection: From State‐of‐the‐Art Laboratories to Smartphone‐Based Point‐of‐Care Testing
Xiao, M., Tian, F., Liu, X., Zhou, Q., Pan, J., Luo, Z., Yang, M., & Yi, C. (2022) · Advanced Science · doi:10.1002/advs.202105904 · Cited by 218
Chan, J. F.-W., Chan, K.-H., Choi, G. K.-Y., To, K. K.-W., Tse, H., Cai, J.-P., Yeung, M. L., Cheng, V. C.-C., Chen, H., Che, X.-Y., et al. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit123 · Cited by 220
Broad-spectrum coronavirus antiviral drug discovery
Totura, A. L., & Bavari, S. (2019) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2019.1581171 · Cited by 218
Tanner, J. A., Watt, R. M., Chai, Y.-B., Lu, L.-Y., Lin, M. C., Peiris, J. S. M., Poon, L. L. M., Kung, H.-F., & Huang, J.-D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c300328200 · Cited by 219
Morgenstern, B., Michaelis, M., Baer, P. C., Doerr, H. W., & Cinatl, J. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.11.128 · Cited by 214
Self-citationEsper, F., Weibel, C., Ferguson, D., Landry, M. L., & Kahn, J. S. (2005) · The Journal of Infectious Diseases · doi:10.1086/428138 · Cited by 219
Xu, X. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg916 · Cited by 224
Almazán, F., DeDiego, M. L., Galán, C., Escors, D., Álvarez, E., Ortego, J., Sola, I., Zuñiga, S., Alonso, S., Moreno, J. L., et al. (2006) · Journal of Virology · doi:10.1128/jvi.00385-06 · Cited by 221
Analysis of Intraviral Protein-Protein Interactions of the SARS Coronavirus ORFeome
von Brunn, A., Teepe, C., Simpson, J. C., Pepperkok, R., Friedel, C. C., Zimmer, R., Roberts, R., Baric, R., & Haas, J. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000459 · Cited by 221
Han, D. P., Penn-Nicholson, A., & Cho, M. W. (2006) · Virology · doi:10.1016/j.virol.2006.01.029 · Cited by 214
LY6E impairs coronavirus fusion and confers immune control of viral disease
Pfaender, S., Mar, K. B., Michailidis, E., Kratzel, A., Boys, I. N., V’kovski, P., Fan, W., Kelly, J. N., Hirt, D., Ebert, N., et al. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0769-y · Cited by 221
DeDiego, M. L., Nieto-Torres, J. L., Jiménez-Guardeño, J. M., Regla-Nava, J. A., Álvarez, E., Oliveros, J. C., Zhao, J., Fett, C., Perlman, S., & Enjuanes, L. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002315 · Cited by 218
Coronavirus E protein forms ion channels with functionally and structurally-involved membrane lipids
Verdiá-Báguena, C., Nieto-Torres, J. L., Alcaraz, A., DeDiego, M. L., Torres, J., Aguilella, V. M., & Enjuanes, L. (2012) · Virology · doi:10.1016/j.virol.2012.07.005 · Cited by 217
Coronaviruses: Methods and Protocols
(2015) · Methods in Molecular Biology · doi:10.1007/978-1-4939-2438-7 · Cited by 209
Xiao, S., Tian, Z., Wang, Y., Si, L., Zhang, L., & Zhou, D. (2018) · Medicinal Research Reviews · doi:10.1002/med.21484 · Cited by 213
Matricardi, P. M., Dal Negro, R. W., & Nisini, R. (2020) · Pediatric Allergy and Immunology · doi:10.1111/pai.13271 · Cited by 211
Broad-Spectrum Antiviral Strategies and Nucleoside Analogues
Geraghty, R., Aliota, M., & Bonnac, L. (2021) · Viruses · doi:10.3390/v13040667 · Cited by 208
SARS-CoV-2 ORF10 suppresses the antiviral innate immune response by degrading MAVS through mitophagy
Li, X., Hou, P., Ma, W., Wang, X., Wang, H., Yu, Z., Chang, H., Wang, T., Jin, S., Wang, X., et al. (2022) · Cellular & Molecular Immunology · doi:10.1038/s41423-021-00807-4 · Cited by 214
Human coronavirus NL63, a new respiratory virus
van der Hoek, L., Pyrc, K., & Berkhout, B. (2006) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2006.00032.x · Cited by 211
Rebendenne, A., Chaves Valadão, A. L., Tauziet, M., Maarifi, G., Bonaventure, B., McKellar, J., Planès, R., Nisole, S., Arnaud-Arnould, M., Moncorgé, O., et al. (2021) · Journal of Virology · doi:10.1128/jvi.02415-20 · Cited by 229
3C-like Proteinase from SARS Coronavirus Catalyzes Substrate Hydrolysis by a General Base Mechanism
Huang, C., Wei, P., Fan, K., Liu, Y., & Lai, L. (2004) · Biochemistry · doi:10.1021/bi036022q · Cited by 215
Severe acute respiratory syndrome vs. the Middle East respiratory syndrome
Hui, D. S., Memish, Z. A., & Zumla, A. (2014) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000046 · Cited by 209
Tan, Y.-J., Fielding, B. C., Goh, P.-Y., Shen, S., Tan, T. H. P., Lim, S. G., & Hong, W. (2004) · Journal of Virology · doi:10.1128/jvi.78.24.14043-14047.2004 · Cited by 210
High–Dose Pulse Versus Nonpulse Corticosteroid Regimens in Severe Acute Respiratory Syndrome
Ho, J. C., Ooi, G. C., Mok, T. Y., Chan, J. W., Hung, I., Lam, B., Wong, P. C., Li, P. C., Ho, P. L., Lam, W. K., et al. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200306-766oc · Cited by 208
Orooji, Y., Sohrabi, H., Hemmat, N., Oroojalian, F., Baradaran, B., Mokhtarzadeh, A., Mohaghegh, M., & Karimi-Maleh, H. (2021) · Nano-Micro Letters · doi:10.1007/s40820-020-00533-y · Cited by 206
Jacobs, J., Grum-Tokars, V., Zhou, Y., Turlington, M., Saldanha, S. A., Chase, P., Eggler, A., Dawson, E. S., Baez-Santos, Y. M., Tomar, S., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm301580n · Cited by 200
Leung, D. T. M., Tam, F. C. H., Ma, C. H., Chan, P. K. S., Cheung, J. L. K., Niu, H., Tam, J. S. L., & Lim, P. L. (2004) · The Journal of Infectious Diseases · doi:10.1086/422040 · Cited by 212
Lapointe, C. P., Grosely, R., Johnson, A. G., Wang, J., Fernández, I. S., & Puglisi, J. D. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2017715118 · Cited by 211
Müller, M. A., Raj, V. S., Muth, D., Meyer, B., Kallies, S., Smits, S. L., Wollny, R., Bestebroer, T. M., Specht, S., Suliman, T., et al. (2012) · mBio · doi:10.1128/mbio.00515-12 · Cited by 209
Self-citationIndomethacin Has a Potent Antiviral Activity against Sars Coronavirus
Amici, C., Caro, A. D., Ciucci, A., Chiappa, L., Castilletti, C., Martella, V., Decaro, N., Buonavoglia, C., Capobianchi, M. R., & Santoro, M. G. (2006) · Antiviral Therapy · doi:10.1177/135965350601100803 · Cited by 203
Tanaka, T., Kamitani, W., DeDiego, M. L., Enjuanes, L., & Matsuura, Y. (2012) · Journal of Virology · doi:10.1128/jvi.01700-12 · Cited by 210
High-Throughput Screening Identifies Inhibitors of the SARS Coronavirus Main Proteinase
Blanchard, J. E., Elowe, N. H., Huitema, C., Fortin, P. D., Cechetto, J. D., Eltis, L. D., & Brown, E. D. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.08.011 · Cited by 206
Honda-Okubo, Y., Barnard, D., Ong, C. H., Peng, B.-H., Tseng, C.-T. K., & Petrovsky, N. (2015) · Journal of Virology · doi:10.1128/jvi.02980-14 · Cited by 210
MAVS-Mediated Apoptosis and Its Inhibition by Viral Proteins
Lei, Y., Moore, C. B., Liesman, R. M., O'Connor, B. P., Bergstralh, D. T., Chen, Z. J., Pickles, R. J., & Ting, J. P.-Y. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005466 · Cited by 208
Kulkarni, S. A., Nagarajan, S. K., Ramesh, V., Palaniyandi, V., Selvam, S. P., & Madhavan, T. (2020) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2020.128823 · Cited by 203
McAuliffe, J., Vogel, L., Roberts, A., Fahle, G., Fischer, S., Shieh, W.-J., Butler, E., Zaki, S., St. Claire, M., Murphy, B., et al. (2004) · Virology · doi:10.1016/j.virol.2004.09.030 · Cited by 208
Saikatendu, K. S., Joseph, J. S., Subramanian, V., Clayton, T., Griffith, M., Moy, K., Velasquez, J., Neuman, B. W., Buchmeier, M. J., Stevens, R. C., et al. (2005) · Structure · doi:10.1016/j.str.2005.07.022 · Cited by 204
The Nucleoprotein Is Required for Efficient Coronavirus Genome Replication
Almazán, F., Galán, C., & Enjuanes, L. (2004) · Journal of Virology · doi:10.1128/jvi.78.22.12683-12688.2004 · Cited by 205
The WHO global influenza surveillance and response system (GISRS)—A future perspective
Hay, A. J., & McCauley, J. W. (2018) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12565 · Cited by 195
Hsieh, P.-K., Chang, S. C., Huang, C.-C., Lee, T.-T., Hsiao, C.-W., Kou, Y.-H., Chen, I.-Y., Chang, C.-K., Huang, T.-H., & Chang, M.-F. (2005) · Journal of Virology · doi:10.1128/jvi.79.22.13848-13855.2005 · Cited by 200
Darnell, M. E. R., & Taylor, D. R. (2006) · Transfusion · doi:10.1111/j.1537-2995.2006.00976.x · Cited by 202
Replication of human coronaviruses SARS-CoV, HCoV-NL63 and HCoV-229E is inhibited by the drug FK506
Carbajo-Lozoya, J., Müller, M. A., Kallies, S., Thiel, V., Drosten, C., & von Brunn, A. (2012) · Virus Research · doi:10.1016/j.virusres.2012.02.002 · Cited by 201
Self-citationKindler, E., Jónsdóttir, H. R., Muth, D., Hamming, O. J., Hartmann, R., Rodriguez, R., Geffers, R., Fouchier, R. A. M., Drosten, C., Müller, M. A., et al. (2013) · mBio · doi:10.1128/mbio.00611-12 · Cited by 202
Self-citationEarly diagnosis of SARS Coronavirus infection by real time RT-PCR
Poon, L. L. M., Chan, K. H., Wong, O. K., Yam, W. C., Yuen, K. Y., Guan, Y., Lo, Y. M. D., & Peiris, J. S. M. (2003) · Journal of Clinical Virology · doi:10.1016/j.jcv.2003.08.004 · Cited by 198
Hofmann, H., Hattermann, K., Marzi, A., Gramberg, T., Geier, M., Krumbiegel, M., Kuate, S., Überla, K., Niedrig, M., & Pöhlmann, S. (2004) · Journal of Virology · doi:10.1128/jvi.78.12.6134-6142.2004 · Cited by 199
Dipeptidyl peptidase-4 (DPP4) inhibition in COVID-19
Solerte, S. B., Di Sabatino, A., Galli, M., & Fiorina, P. (2020) · Acta Diabetologica · doi:10.1007/s00592-020-01539-z · Cited by 203
Zeng, Z., Yu, H., Chen, H., Qi, W., Chen, L., Chen, G., Yan, W., Chen, T., Ning, Q., Han, M., et al. (2020) · Critical Care · doi:10.1186/s13054-020-03255-0 · Cited by 193
Main protease mutants of SARS-CoV-2 variants remain susceptible to nirmatrelvir
Ullrich, S., Ekanayake, K. B., Otting, G., & Nitsche, C. (2022) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2022.128629 · Cited by 190
Structural Characterization of the SARS-Coronavirus Spike S Fusion Protein Core
Tripet, B., Howard, M. W., Jobling, M., Holmes, R. K., Holmes, K. V., & Hodges, R. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400759200 · Cited by 198
Muller, M. P., Tomlinson, G., Marrie, T. J., Tang, P., McGeer, A., Low, D. E., Detsky, A. S., & Gold, W. L. (2005) · Clinical Infectious Diseases · doi:10.1086/428577 · Cited by 195
Initial viral load and the outcomes of SARS
Chu, C.-M. (2004) · Canadian Medical Association Journal · doi:10.1503/cmaj.1040398 · Cited by 196
Characterizations of SARS-CoV-2 mutational profile, spike protein stability and viral transmission
Laha, S., Chakraborty, J., Das, S., Manna, S. K., Biswas, S., & Chatterjee, R. (2020) · Infection, Genetics and Evolution · doi:10.1016/j.meegid.2020.104445 · Cited by 200
Chang, C.-K., Hsu, Y.-L., Chang, Y.-H., Chao, F.-A., Wu, M.-C., Huang, Y.-S., Hu, C.-K., & Huang, T.-H. (2009) · Journal of Virology · doi:10.1128/jvi.02001-08 · Cited by 198
Artesi, M., Bontems, S., Göbbels, P., Franckh, M., Maes, P., Boreux, R., Meex, C., Melin, P., Hayette, M.-P., Bours, V., et al. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.01598-20 · Cited by 194
One year update on the COVID-19 pandemic: Where are we now?
Mishra, S. K., & Tripathi, T. (2021) · Acta Tropica · doi:10.1016/j.actatropica.2020.105778 · Cited by 191
Lokugamage, K. G., Narayanan, K., Huang, C., & Makino, S. (2012) · Journal of Virology · doi:10.1128/jvi.01958-12 · Cited by 199
Muth, D., Corman, V. M., Roth, H., Binger, T., Dijkman, R., Gottula, L. T., Gloza-Rausch, F., Balboni, A., Battilani, M., Rihtarič, D., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-33487-8 · Cited by 197
Self-citationZhou, P., Yuan, M., Song, G., Beutler, N., Shaabani, N., Huang, D., He, W.-T., Zhu, X., Callaghan, S., Yong, P., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abi9215 · Cited by 204
Cheung, T. M. T., Yam, L. Y. C., So, L. K. Y., Lau, A. C. W., Poon, E., Kong, B. M. H., & Yung, R. W. H. (2004) · Chest · doi:10.1378/chest.126.3.845 · Cited by 191
Chen, L., Gui, C., Luo, X., Yang, Q., Günther, S., Scandella, E., Drosten, C., Bai, D., He, X., Ludewig, B., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.11.7095-7103.2005 · Cited by 191
Self-citationPathogenetic mechanisms of severe acute respiratory syndrome
Guo, Y., Korteweg, C., McNutt, M. A., & Gu, J. (2008) · Virus Research · doi:10.1016/j.virusres.2007.01.022 · Cited by 188
Lau, S. K. P., Feng, Y., Chen, H., Luk, H. K. H., Yang, W.-H., Li, K. S. M., Zhang, Y.-Z., Huang, Y., Song, Z.-Z., Chow, W.-N., et al. (2015) · Journal of Virology · doi:10.1128/jvi.01048-15 · Cited by 193
Middle East Respiratory Syndrome Coronavirus Accessory Protein 4a Is a Type I Interferon Antagonist
Niemeyer, D., Zillinger, T., Muth, D., Zielecki, F., Horvath, G., Suliman, T., Barchet, W., Weber, F., Drosten, C., & Müller, M. A. (2013) · Journal of Virology · doi:10.1128/jvi.01845-13 · Cited by 195
Self-citationGlobal research trends of World Health Organization’s top eight emerging pathogens
Sweileh, W. M. (2017) · Globalization and Health · doi:10.1186/s12992-017-0233-9 · Cited by 188
The global spread of 2019-nCoV: a molecular evolutionary analysis
Benvenuto, D., Giovanetti, M., Salemi, M., Prosperi, M., De Flora, C., Junior Alcantara, L. C., Angeletti, S., & Ciccozzi, M. (2020) · Pathogens and Global Health · doi:10.1080/20477724.2020.1725339 · Cited by 193
Approaches to the management of patients in oral and maxillofacial surgery during COVID-19 pandemic
Zimmermann, M., & Nkenke, E. (2020) · Journal of Cranio-Maxillofacial Surgery · doi:10.1016/j.jcms.2020.03.011 · Cited by 190
The Impact of Pre-existing Comorbidities and Therapeutic Interventions on COVID-19
Callender, L. A., Curran, M., Bates, S. M., Mairesse, M., Weigandt, J., & Betts, C. J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01991 · Cited by 188
The dominance of human coronavirus OC43 and NL63 infections in infants
Dijkman, R., Jebbink, M. F., Gaunt, E., Rossen, J. W. A., Templeton, K. E., Kuijpers, T. W., & van der Hoek, L. (2012) · Journal of Clinical Virology · doi:10.1016/j.jcv.2011.11.011 · Cited by 190
Detection and Prevalence Patterns of Group I Coronaviruses in Bats, Northern Germany
Gloza-Rausch, F., Ipsen, A., Seebens, A., Göttsche, M., Panning, M., Drexler, J. F., Petersen, N., Annan, A., Grywna, K., Müller, M., et al. (2008) · Emerging Infectious Diseases · doi:10.3201/eid1404.071439 · Cited by 190
Self-citationMolecular Mechanism of Evolution and Human Infection with SARS-CoV-2
He, J., Tao, H., Yan, Y., Huang, S.-Y., & Xiao, Y. (2020) · Viruses · doi:10.3390/v12040428 · Cited by 187
Sainz, B., Mossel, E. C., Peters, C. J., & Garry, R. F. (2004) · Virology · doi:10.1016/j.virol.2004.08.011 · Cited by 188
MO, H., ZENG, G., REN, X., LI, H., KE, C., TAN, Y., CAI, C., LAI, K., CHEN, R., CHAN‐YEUNG, M., et al. (2006) · Respirology · doi:10.1111/j.1440-1843.2006.00783.x · Cited by 193
Charlton, C. L., Babady, E., Ginocchio, C. C., Hatchette, T. F., Jerris, R. C., Li, Y., Loeffelholz, M., McCarter, Y. S., Miller, M. B., Novak-Weekley, S., et al. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00042-18 · Cited by 188
Grum-Tokars, V., Ratia, K., Begaye, A., Baker, S. C., & Mesecar, A. D. (2008) · Virus Research · doi:10.1016/j.virusres.2007.02.015 · Cited by 190
Shi, J., Wei, Z., & Song, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311744200 · Cited by 190
Yoshikawa, T., Hill, T. E., Yoshikawa, N., Popov, V. L., Galindo, C. L., Garner, H. R., Peters, C. J., & Tseng, C.-T. (. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008729 · Cited by 190
Thrombocytopenia in patients with severe acute respiratory syndrome (review)
Yang, M., Ng, M. H., & Li, C. K. (2005) · Hematology · doi:10.1080/10245330400026170 · Cited by 185
Wu, C.-H., Yeh, S.-H., Tsay, Y.-G., Shieh, Y.-H., Kao, C.-L., Chen, Y.-S., Wang, S.-H., Kuo, T.-J., Chen, D.-S., & Chen, P.-J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m805747200 · Cited by 190
The psychological impact of SARS: a matter of heart and mind
Sim, K. (2004) · Canadian Medical Association Journal · doi:10.1503/cmaj.1032003 · Cited by 195
Analyzing the epidemiological outbreak of COVID‐19: A visual exploratory data analysis approach
Dey, S. K., Rahman, M. M., Siddiqi, U. R., & Howlader, A. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25743 · Cited by 186
Mackman, N., Antoniak, S., Wolberg, A. S., Kasthuri, R., & Key, N. S. (2020) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.120.314514 · Cited by 186
Narayanan, K., Ramirez, S. I., Lokugamage, K. G., & Makino, S. (2015) · Virus Research · doi:10.1016/j.virusres.2014.11.019 · Cited by 187
Chen, L., Liu, P., Gao, H., Sun, B., Chao, D., Wang, F., Zhu, Y., Hedenstierna, G., & Wang, C. G. (2004) · Clinical Infectious Diseases · doi:10.1086/425357 · Cited by 186
Middle East respiratory syndrome coronavirus (MERS-CoV): animal to human interaction
Omrani, A. S., Al-Tawfiq, J. A., & Memish, Z. A. (2015) · Pathogens and Global Health · doi:10.1080/20477724.2015.1122852 · Cited by 185
Wang, F., Chen, C., Tan, W., Yang, K., & Yang, H. (2016) · Scientific Reports · doi:10.1038/srep22677 · Cited by 189
Chan, J. Y. K., Wong, E. W. Y., & Lam, W. (2020) · JAMA Otolaryngology–Head & Neck Surgery · doi:10.1001/jamaoto.2020.0488 · Cited by 186
Boozari, M., & Hosseinzadeh, H. (2021) · Phytotherapy Research · doi:10.1002/ptr.6873 · Cited by 184
Metadata
- Authors
- Drosten, C., Günther, S., Preiser, W., van der Werf, S., Brodt, H.-R., Becker, S., Rabenau, H., Panning, M., Kolesnikova, L., Fouchier, R. A. M., Berger, A., Burguière, A.-M., Cinatl, J., Eickmann, M., Escriou, N., Grywna, K., Kramme, S., Manuguerra, J.-C., Müller, S., Rickerts, V., Stürmer, M., Vieth, S., Klenk, H.-D., Osterhaus, A. D. M. E., Schmitz, H., & Doerr, H. W.
- Affiliations
- Goethe University Frankfurt (DE)
- From the Bernhard Nocht Institute for Tropical Medicine, National Reference Center for Tropical Infectious Diseases, Hamburg (C.D., S.G., M.P., K.G., S.K., S.M., S.V., H.S.); the Institute of Medical Virology (W.P., H.R., A.B., J.C., M.S., H.W.D.) and the Medical Clinic III (H.-R.B., V.R.), Johann Wolfgang Goethe University, Frankfurt am Main; and the Institute of Virology, Philipps University, Marburg (S.B., L.K., M.E., H.-D.K.) — all in Germany; the Pasteur Institute, Molecular Genetics of Respiratory...
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-05-15
- Volume
- 348
- Issue
- 20
- Pages
- 1967-1976
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2132260239
- Semantic Scholar
- 79116f5bb552a1a23de85d03899ab0b3763c81ee
- Cited by
- 4,574
- References
- 10
- Citations by year
- 2026: 40 · 2025: 91 · 2024: 141 · 2023: 193 · 2022: 361 · 2021: 646 · 2020: 913 · 2019: 50 · 2018: 45 · 2017: 49 · 2016: 60 · 2015: 65 · 2014: 91 · 2013: 83 · 2012: 93
- FWCI
- 222.93
- Type
- journal article
- Language
- en
- Open access
- green
- pure.eur.nl
- Licence
- other-oa
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, other-oa)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- HAL (submittedVersion, other-oa)
- RePub (Erasmus University Rotterdam) (submittedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Keywords
- SARS, novel coronavirus, SARS-CoV, virus identification, viral RNA detection, seroconversion, fecal viral shedding, plasma viral RNA
- MeSH terms
- Adult, Amino Acid Sequence, Animals, Base Sequence, Cattle, Disease Outbreaks, DNA, Viral, Female, Humans, Male, Molecular Sequence Data, Phylogeny, RNA, Viral, Sequence Homology, Nucleic Acid, Sputum, Polymerase Chain Reaction, Coronavirus, Severe Acute Respiratory Syndrome, Severe acute respiratory syndrome-related coronavirus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.